PayPay Securities’s Moderna MRNA Stock Holding History

PayPay Securities’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.04K	Sell	19 -20	-51%	-$933	0.04%	243
2025 Q4	$1.15K	Sell	39 -1	-3%	-$27	0.03%	246
2025 Q3	$1.04K	Buy	40 +15	+60%	+$418	0.04%	214
2025 Q2	$690	Buy	25 +5	+25%	+$132	0.03%	228
2025 Q1	$586	Sell	20 -4	-17%	-$142	0.03%	247
2024 Q4	$998	Buy	24 +13	+118%	+$621	0.04%	215
2024 Q3	$735	Sell	11 -39	-78%	-$3.58K	0.07%	115
2024 Q2	$5.94K	Sell	50 -9	-15%	-$1.14K	0.5%	45
2024 Q1	$6.29K	Sell	59 -11	-16%	-$1.11K	0.31%	73
2023 Q4	$7.06K	Sell	70 -62	-47%	-$5.21K	0.35%	55
2023 Q3	$13.6K	Buy	132 +124	+1,550%	+$13.8K	0.62%	38
2023 Q2	$972	Sell	8 -9	-53%	-$1.2K	0.06%	152
2023 Q1	$2.61K	Sell	17 -3	-15%	-$495	0.17%	120
2022 Q4	$3.59K	Buy	+20	New	+$3.27K	0.24%	110

Other funds holding MRNA

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Baillie Gifford & Co

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Capital World Investors

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments

Two Sigma Investments New York $121B AUM 33.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return